Previous studies by others showed that hyperactivation of Raf kinase induces the loss of ERα in ERα-positive breast cancer cells [54] and inhibition of mitogen-activated protein kinase (MAPK) activity induced the expression of ERα in ERα-negative breast cancer cells [55]. The gene discussed is ESR1; the disease is breast cancer.